MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0038 (-97.44%)
At close: Sep 17, 2025
MediXall Group Market Cap
MediXall Group has a market cap or net worth of $20.55 thousand as of October 14, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
20.55K
Enterprise Value
596.65K
Revenue
304.34K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 20, 2016, MediXall Group's market cap has decreased from 3.64M to 20.55K, a decrease of -99.44%. That is a compound annual growth rate of -44.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 20.55K | -99.97% |
| Dec 23, 2022 | 77.59M | -31.76% |
| Dec 28, 2021 | 113.70M | 28.06% |
| Dec 28, 2020 | 88.79M | -41.36% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |